Showing results (31-40 of 297) with videos related to
Sort By:
Pageof 30
Clinical Kidney Journal|February 10, 2018
MicroRNAs: a new avenue to understand, investigate and treat immunoglobulin A nephropathy?Haresh Selvaskandan, Izabella Pawluczyk, Jonathan BarrattSeminars in Nephrology|September 5, 2018
Treatment of IgA Nephropathy: Evolution Over Half a CenturyJonathan Barratt, Sydney C W TangNephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 30, 2022
Clinical application of microRNAs in glomerular diseasesHaresh Selvaskandan, Izabella Pawluczyk, Jonathan BarrattBMJ Open|April 2, 2021
Multimethods study comparing the experiences of medical clinical academics with nurses, midwives and allied health professionals pursuing a clinical academic careerDiane Trusson, Emma Rowley, Jonathan BarrattKidney360|April 4, 2022
TRPM2 Plays a Minor Role in AKI and Kidney FibrosisYu Kurata, Tetsuhiro Tanaka, Hana Cernecka, et al.Seminars in Nephrology|May 25, 2004
Pathogenesis of IgA nephropathyJonathan Barratt, John Feehally, Alice C SmithInternational Journal of Immunogenetics|November 25, 2021
Immunological drivers of IgA nephropathy: Exploring the mucosa-kidney linkHaresh Selvaskandan, Jonathan Barratt, Chee Kay CheungNephrology (Carlton, Vic.)|June 3, 2015
Emerging therapies in immunoglobulin A nephropathySee Cheng Yeo, Adrian Liew, Jonathan BarrattFrontiers in Medicine|August 30, 2024
Therapy of IgA nephropathy: time for a paradigm changeJonathan Barratt, Richard A Lafayette, Jürgen FloegeNephrology (Carlton, Vic.)|May 15, 2007
The pathogenic role of IgA1 O-linked glycosylation in the pathogenesis of IgA nephropathyJonathan Barratt, Alice C Smith, John FeehallyPageof 30